Results 241 to 250 of about 219,700 (321)
Differences in Hospitalization and Inpatient Death Patterns by Incarceration Status in 31 US Jurisdictions, 2021. [PDF]
Kennedy BS, Richeson RP, Houde AJ.
europepmc +1 more source
The Structure of Informal Learning in the Workplace—An Experience Sampling Approach
ABSTRACT This paper complements retrospective approaches to researching informal learning in the workplace with experience sampling. Since (conscious) informal learning is becoming increasingly important for successfully keeping pace with rapid changes in working environments, a clear understanding of the construct and its precise measurement are ...
Katja Häußermann, Tina Seufert
wiley +1 more source
A Review of R Packages for Bayesian Model-based Clustering of High-dimensional Multivariate Environmental Exposures. [PDF]
Stephenson BJK, Fu Y.
europepmc +1 more source
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed +10 more
wiley +1 more source
New Modified Generalized Inverted Exponential Distribution and Its Applications. [PDF]
Al-Saiary ZA, Al-Jammaz HH.
europepmc +1 more source
Long‐term benefit from adjuvant tamoxifen therapy for ER+ HER2− breast cancer by PR positivity
What's New? Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer. Its long‐term benefits, however, may vary by progesterone receptor (PR) status. Here, using data from the Stockholm tamoxifen trials, the authors evaluated whether PR expression predicts
Anna E. Nordenskjöld +8 more
wiley +1 more source
Brixia score on initial chest X-ray as a predictor of outcome in COVID-19 and H1N1 acute chest infections: A retrospective study. [PDF]
Khasawneh R +6 more
europepmc +1 more source
What's New? Balancing efficacy and tolerability is challenging in oncology, as standard dosing often prioritizes maximum tolerated doses over other patient needs. Here, the authors developed a predictive index to identify patients with increased probability of dose reduction in metastatic breast cancer and compared the real‐world effectiveness of ...
Patrick Marschner +19 more
wiley +1 more source

